Strongbridge Biopharma plc
SBBP · NASDAQ
6/30/2021 | 3/31/2021 | 12/31/2020 | 9/30/2020 | |
|---|---|---|---|---|
| Market Cap | $200,931 | $185,956 | $136,336 | $117,821 |
| - Cash | $63,774 | $73,898 | $87,522 | $81,793 |
| + Debt | $18,147 | $17,825 | $17,276 | $7,679 |
| Enterprise Value | $155,304 | $129,883 | $66,090 | $43,707 |
| Revenue | $10,042 | $8,382 | $8,226 | $8,071 |
| % Growth | 19.8% | 1.9% | 1.9% | – |
| Gross Profit | $9,575 | $7,971 | $7,784 | $7,663 |
| % Margin | 95.3% | 95.1% | 94.6% | 94.9% |
| EBITDA | -$11,153 | -$9,755 | -$10,124 | -$1,360 |
| % Margin | -111.1% | -116.4% | -123.1% | -16.9% |
| Net Income | -$13,241 | -$11,814 | -$11,946 | -$3,159 |
| % Margin | -131.9% | -140.9% | -145.2% | -39.1% |
| EPS Diluted | -0.19 | -0.18 | -0.21 | -0.055 |
| % Growth | -5.6% | 14.3% | -281.8% | – |
| Operating Cash Flow | -$9,827 | -$13,393 | -$5,000 | -$5,759 |
| Capital Expenditures | $0 | -$10 | $0 | -$10 |
| Free Cash Flow | -$9,827 | -$13,403 | -$5,000 | -$5,769 |